Is Huachansu Beneficial in Treating Advanced Non-Small-Cell Lung Cancer? Evidence from a Meta-Analysis of Its Efficacy Combined with Chemotherapy
Background. Huachansu, the sterilized water extract of Bufo bufo gargarizans toad skin, is used in China to alleviate the side-effects and enhance the therapeutic effect of chemotherapy in advanced non-small-cell lung cancer (NSCLC). We conducted a meta-analysis to assess Huachansu’s efficacy. Metho...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2015/408145 |
id |
doaj-107782383a814f10a2265be355366bc5 |
---|---|
record_format |
Article |
spelling |
doaj-107782383a814f10a2265be355366bc52020-11-24T22:02:18ZengHindawi LimitedEvidence-Based Complementary and Alternative Medicine1741-427X1741-42882015-01-01201510.1155/2015/408145408145Is Huachansu Beneficial in Treating Advanced Non-Small-Cell Lung Cancer? Evidence from a Meta-Analysis of Its Efficacy Combined with ChemotherapyBingduo Zhou0Fengying Wu1Lin Yuan2Zhulei Miao3Shengliang Zhu4Department of Gastroenterology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, ChinaDepartment of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, ChinaScience and Technology Experimental Center, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, ChinaDepartment of Immunology and Pathogen Biology, School of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, ChinaDepartment of Gastroenterology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, ChinaBackground. Huachansu, the sterilized water extract of Bufo bufo gargarizans toad skin, is used in China to alleviate the side-effects and enhance the therapeutic effect of chemotherapy in advanced non-small-cell lung cancer (NSCLC). We conducted a meta-analysis to assess Huachansu’s efficacy. Methods. We extensively searched electronic databases (CENTRAL, EMBASE, MEDLINE, CBM, Cochrane Library, CNKI, CEBM, WFDP, CSCD, CSTD, and IPA) for randomized controlled trials containing Huachansu plus chemotherapy as the test group and chemotherapy as the control group. Seventeen trials were selected based on the selection criteria. The pooled relative ratio (RR) of indicators with 95% confidence interval (95% CI) was calculated for efficacy evaluation. Results. The meta-analysis demonstrated a statistically significant improvement in objective tumor response, one-year survival, Karnofsky performance status, pain relief, and alleviation of severe side-effects (nausea and vomiting, leukocytopenia) in the test group as compared to the control group, but no significant difference in thrombocytopenia. Conclusions. This study demonstrated the efficacy of Huachansu combined with chemotherapy in the treatment of advanced NSCLC. However, limitations exist and high-quality trials are needed for further verification.http://dx.doi.org/10.1155/2015/408145 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Bingduo Zhou Fengying Wu Lin Yuan Zhulei Miao Shengliang Zhu |
spellingShingle |
Bingduo Zhou Fengying Wu Lin Yuan Zhulei Miao Shengliang Zhu Is Huachansu Beneficial in Treating Advanced Non-Small-Cell Lung Cancer? Evidence from a Meta-Analysis of Its Efficacy Combined with Chemotherapy Evidence-Based Complementary and Alternative Medicine |
author_facet |
Bingduo Zhou Fengying Wu Lin Yuan Zhulei Miao Shengliang Zhu |
author_sort |
Bingduo Zhou |
title |
Is Huachansu Beneficial in Treating Advanced Non-Small-Cell Lung Cancer? Evidence from a Meta-Analysis of Its Efficacy Combined with Chemotherapy |
title_short |
Is Huachansu Beneficial in Treating Advanced Non-Small-Cell Lung Cancer? Evidence from a Meta-Analysis of Its Efficacy Combined with Chemotherapy |
title_full |
Is Huachansu Beneficial in Treating Advanced Non-Small-Cell Lung Cancer? Evidence from a Meta-Analysis of Its Efficacy Combined with Chemotherapy |
title_fullStr |
Is Huachansu Beneficial in Treating Advanced Non-Small-Cell Lung Cancer? Evidence from a Meta-Analysis of Its Efficacy Combined with Chemotherapy |
title_full_unstemmed |
Is Huachansu Beneficial in Treating Advanced Non-Small-Cell Lung Cancer? Evidence from a Meta-Analysis of Its Efficacy Combined with Chemotherapy |
title_sort |
is huachansu beneficial in treating advanced non-small-cell lung cancer? evidence from a meta-analysis of its efficacy combined with chemotherapy |
publisher |
Hindawi Limited |
series |
Evidence-Based Complementary and Alternative Medicine |
issn |
1741-427X 1741-4288 |
publishDate |
2015-01-01 |
description |
Background. Huachansu, the sterilized water extract of Bufo bufo gargarizans toad skin, is used in China to alleviate the side-effects and enhance the therapeutic effect of chemotherapy in advanced non-small-cell lung cancer (NSCLC). We conducted a meta-analysis to assess Huachansu’s efficacy. Methods. We extensively searched electronic databases (CENTRAL, EMBASE, MEDLINE, CBM, Cochrane Library, CNKI, CEBM, WFDP, CSCD, CSTD, and IPA) for randomized controlled trials containing Huachansu plus chemotherapy as the test group and chemotherapy as the control group. Seventeen trials were selected based on the selection criteria. The pooled relative ratio (RR) of indicators with 95% confidence interval (95% CI) was calculated for efficacy evaluation. Results. The meta-analysis demonstrated a statistically significant improvement in objective tumor response, one-year survival, Karnofsky performance status, pain relief, and alleviation of severe side-effects (nausea and vomiting, leukocytopenia) in the test group as compared to the control group, but no significant difference in thrombocytopenia. Conclusions. This study demonstrated the efficacy of Huachansu combined with chemotherapy in the treatment of advanced NSCLC. However, limitations exist and high-quality trials are needed for further verification. |
url |
http://dx.doi.org/10.1155/2015/408145 |
work_keys_str_mv |
AT bingduozhou ishuachansubeneficialintreatingadvancednonsmallcelllungcancerevidencefromametaanalysisofitsefficacycombinedwithchemotherapy AT fengyingwu ishuachansubeneficialintreatingadvancednonsmallcelllungcancerevidencefromametaanalysisofitsefficacycombinedwithchemotherapy AT linyuan ishuachansubeneficialintreatingadvancednonsmallcelllungcancerevidencefromametaanalysisofitsefficacycombinedwithchemotherapy AT zhuleimiao ishuachansubeneficialintreatingadvancednonsmallcelllungcancerevidencefromametaanalysisofitsefficacycombinedwithchemotherapy AT shengliangzhu ishuachansubeneficialintreatingadvancednonsmallcelllungcancerevidencefromametaanalysisofitsefficacycombinedwithchemotherapy |
_version_ |
1725836577181007872 |